National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024
15Maximum quantity (number of units)—related pharmaceutical benefits
Start here
Get a plain-English read of 15
Turn the raw legal text into a practical explanation grounded in National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024.
15 Maximum quantity (number of units)—related pharmaceutical benefits
(1) For the purposes of paragraph 85A(2)(a) of the Act, this section determines the maximum number of units of the pharmaceutical item in a related pharmaceutical benefit that an authorised prescriber may, in one prescription for a special arrangement supply of the benefit, direct to be supplied on any one occasion. (2) If only one number of units is mentioned in the column of the table in Schedule 2 headed “Maximum Quantity” in relation to brands of the pharmaceutical item, that number of units is the maximum number of units of the pharmaceutical item for all purposes. (3) If more than one number of units is mentioned in the column of the table in Schedule 2 headed “Maximum Quantity” in relation to brands of the pharmaceutical item, then: (a) if a purposes code is mentioned in the column of the table headed “Purposes” in relation to a number of units—that number is the maximum number of units of the pharmaceutical item for the purposes mentioned in the table in Part 1 of Schedule 3 for that purposes code; and (b) if no purposes code is mentioned in the column in relation to a number of units—that number is the maximum number of units of the pharmaceutical item for all purposes other than purposes to which paragraph (a) applies. Application of this section (4) To the extent that this section provides for a matter not provided for in the Listing Instrument, this section applies in addition to the Listing Instrument. (5) To the extent that this section makes a different provision for a matter provided for in the Listing Instrument, this section applies despite the Listing Instrument.